Nrx pharmaceuticals announces the appointment of stephen willard, chief executive officer and director

Extensive experience in law, finance, and management of public and private biotechnology companies proven track record of creating value for shareholders national science board presidential appointee, 2018-2024 former roles at federal deposit insurance corporation (fdic) and e*trade financial radnor, pa. , july 13, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp): ("nrx pharmaceuticals", or the "company"), a clinical-stage biopharmaceutical company, today announced the appointment of stephen willard, as its chief executive officer ("ceo") and a member of the company's board of directors.
NRXP Ratings Summary
NRXP Quant Ranking